Gainers

• Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular session. The market value of their outstanding shares is at $17.4 billion. The company's, Q2 earnings came out yesterday.
• MindWalk Holdings (NASDAQ:HYFT) shares increased by 16.1% to $1.37. The company's market cap stands at $55.1 million. As per the press release, Q4 earnings came out 2 days ago.
• Werewolf Therapeutics (NASDAQ:HOWL) shares rose 14.76% to $0.41. The company's market cap stands at $17.5 million.
• Onconetix (NASDAQ:ONCO) shares moved upwards by 11.34% to $0.88. The company's market cap stands at $2.9 million.
• ORIC Pharmaceuticals (NASDAQ:ORIC) stock rose 11.01% to $12.09. The market value of their outstanding shares is at $1.1 billion.
• CytoMed Therapeutics (NASDAQ:GDTC) stock increased by 9.68% to $0.97. The company's market cap stands at $10.4 million.

Losers

• China SXT Pharmaceuticals (NASDAQ:SXTC) stock decreased by 80.0% to $0.07 during Friday's regular session. The market value of their outstanding shares is at $12.7 million.
• Catheter Precision (AMEX:VTAK) stock fell 39.63% to $0.25. The market value of their outstanding shares is at $1.4 million.
• Codexis (NASDAQ:CDXS) shares decreased by 24.88% to $1.5. The company's market cap stands at $180.8 million.
• Zevra Therapeutics (NASDAQ:ZVRA) stock fell 24.73% to $9.43. The company's market cap stands at $740.1 million.
• Jupiter Neurosciences (NASDAQ:JUNS) stock declined by 19.81% to $0.12. The market value of their outstanding shares is at $7.3 million.
• Radiopharm Theranostics (NASDAQ:RADX) stock declined by 17.95% to $3.52. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.